Thomas Frisell

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Temporal Trends in the Incidence and Prevalence of Multiple Sclerosis in Sweden, 2001-2021.

Temporal Trends in the Incidence and Prevalence of Multiple Sclerosis in Sweden, 2001-2021.

Journal: Neuroepidemiology

Published: March 17, 2026

Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.

Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.

Journal: Neuroepidemiology

Published: March 17, 2026

Nationwide estimates of all-cause and cause-specific mortality among individuals with gender dysphoria in Sweden, 2001-2023: a register-based cohort study.

Nationwide estimates of all-cause and cause-specific mortality among individuals with gender dysphoria in Sweden, 2001-2023: a register-based cohort study.

Journal: EClinicalMedicine

Published: February 25, 2026

Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

Journal: European journal of neurology

Published: February 04, 2026

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Journal: Journal of the National Cancer Institute

Published: January 31, 2026

Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.

Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.

Journal: Annals of neurology

Published: January 16, 2026

Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year study.

Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year study.

Journal: Annals of the rheumatic diseases

Published: October 31, 2025

Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide study.

Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide study.

Journal: Annals of the rheumatic diseases

Published: October 24, 2025

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Journal: Annals of clinical and translational neurology

Published: September 22, 2025

Stability After Legal Gender Change Among Adults With Gender Dysphoria.

Stability After Legal Gender Change Among Adults With Gender Dysphoria.

Journal: JAMA network open

Published: September 04, 2025

Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial.

Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial.

Journal: European journal of neurology

Published: July 08, 2025

No evidence for the validity of ICE FALCON.

No evidence for the validity of ICE FALCON.

Journal: International journal of epidemiology

Published: May 23, 2025

Showing 1-12 of 132

Last Updated: 09/26/2026